of HIV-1-infected PBMC between group 2 and group 3 patients may in part reflect the loss of CD4+ T lymphocytes in more advanced stages of the disease. However, the results clearly indicate a striking coincidence between the fall of the CD4+ T-cell count below 400/gil and the sharp increase in PBMC virus loading and p24
antigenemia. Since the procedure is relatively easy to perform, it could be used to monitor the evolution of HIV-1 infection and may prove a useful adjunct in tailoring therapeutic strategies.
A dramatic decrease in the number of circulating CD4+ helper-inducer T lymphocytes, followed by a profound derangement of the immune response, is the hallmark of disease progression in human immunodeficiency virus type 1 (HIV-1)-infected patients (17, 21, 22, 25) .
The quantification of peripheral blood mononuclear cells (PBMC) productively or latently infected by HIV-1 is essential to understand various pathogenic aspects of the disease, better define the stage of the disease, and tailor therapeutic strategies. Different technical procedures have been used to assess the frequency of HIV-1-infected cells in the bloodstream (5, 28) , lymphonodi (15, 20) , and other regions of the body (17) . Although some studies have furnished interesting new data, conflicting results have been reported. While initial studies demonstrated that only 1 or fewer in 100 CD4+ T cells harbored HIV-1 provirus (5, (27) (28) (29) , subsequent research suggested that the percentage of infected PBMC may be much higher than previously described (1-4, 9, 15, 23, 26) . The different percentages reported by different authors may be due, in part, to technical differences in the various studies. A current limitation of PCR on extracted DNA is the difficulty in correlating the presence of the viral genome with a single cell and thus determining the exact percentage of HIV-1-carrying cells (13) . On can detect a single infected cell, it requires microscopical screening of a large number of cells to determine the exact percentage of HIV-1-harboring cells (1, 18) . The combination of in situ PCR and flow cytometry analysis, instead, can overcome most these drawbacks (23, 31) .
Knowing the percentage of HIV-1-infected PBMC during the different stages of the disease may provide important information. We therefore investigated the presence of HIV-1 proviral DNA in the PBMC of three groups of HIV-1-seropositive patients, using a newly developed flow cytometry analysis of the product of in situ PCR assay in comparison with other markers (HIV-1 p24 antigenemia and virus isolation) of infection.
MATERIALS AND METHODS
Patients and controls. Peripheral blood samples were obtained from 53 HIV-1-seropositive subjects classified on the basis of the 1993 Centers for Disease Control revised classification system for HIV infection (7) and from 15 In situ PCR. The reaction was carried out by a newly developed method of flow cytometry analysis of the product of in situ PCR assay. The method was derived, with slight modifications, from methods already described in reports from our (13, 16) and other (23, 31) To assess the DNA amplification capability and positive signal detection in the system employed, samples were analyzed in parallel with oligonucleotide primers GH26 and GH27 (Perkin-Elmer Cetus), which flank a conserved region of the HLA-DQ (oi) locus, as previously described (12) . A couple of lambda phage-specific oligonucleotide primers (5'-GATGA GTTCGTGTCCGTACAACTGG-3', mapping at positions 7131 to 7155, and 5'-GGITATCGAAATCAGCCACAGCG CC-3', mapping at positions 7606 to 7630) which have no homologies with HIV-1 or cellular DNA were used as negative controls.
Construction of a standard curve and positive control for PCR assays. The 8E5/ILAV cell line (11) , which contains a single copy of the HIV-1 provirus genome per cell, was used as a positive control to verify both the specificity and sensitivity of the test.
Cells were passed twice a week in RPMI 1640 supplemented with 10% fetal calf serum (GIBCO).
Cells in the mid-log phase of growth were washed in PBS and counted in a hemocytometer. To assess the lowest limit of positive signal detection by the procedure employed and to construct a standard curve for PCR assays, 8E5/LAV cells were mixed with uninfected lymphoblastoid A3.01 cells (10) mixed cell populations containing from 0.05 to 100% HIV-1 DNA-positive cells to ascertain the sensitivity of the test in our experimental conditions. A negative PCR signal was consistently obtained when 8E5/LAV cells were present at a frequency of <0.1%, which means that the lower limit for positive signal detection by the procedure was about 10 proviral genomes in a background of 10,000 cells.
No positive signal over the background was ever observed when DNA polymerase was omitted or lambda phage-specific primers were used. Nonspecific fluorescein-conjugated antidigoxigenin antibody staining was not detected. Figure 3 shows an example of positive and negative cells with stained nuclei.
Percentage of HIV-1 provirus genome-containing PBMC detected by in situ PCR. As expected, all HIV-1-seropositive patients showed detectable levels of HIV-1 provirus DNA in PBMC, with percentages of positive cells ranging from 0.6 to 20%. Two representative histograms from patients with divergent values are illustrated in Fig. 2D and E.
The percentages of infected PBMC differed in the three categories of HIV-1-seropositive patients studied. The first group of subjects showed a mean value of infected PBMC of 2.1% ± 1.7% (with a range of positivity from 0.6 to 7.3%), while the other two categories presented mean values of 6.5% + 4.1% and 4.9% ± 4.7% (with ranges of positivity from 1.2 to 11.3% and from 0.8 to 20.0%), respectively (Table 1) .
These differences were significant between the first and second groups of patients (P < 0.001) and between the first and the third (P < 0.05). The differences remained significant when the percentages of infected PBMC were normalized for the CD4+ cells (T4 lymphocytes plus monocytes) estimated to be present in each sample analyzed by the flow cytometer (Fig.  4) . Figure 4 shows the normalized percentage of HIV-1 provirus-containing CD4+ cells and p24 antigenemia (picograms per milliliter) of each subject plotted against the absolute number of CD4+ T lymphocytes per microliter.
As can be seen, the percentage of virus-infected CD4+ cells and the absolute values of p24 antigenemia were consistently higher for patients with a CD4+ T-cell count below 400/,ul than for patients having higher CD4+ T-cell counts.
No significant differences in the percentages of HIV-1-infected CD4+ cells were observed between the patients 
